Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer’s Disease

Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer’s Disease

Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer’s Disease

Literature Citation

Huei-Chun Liu, Chin-Yi Lin, Hsin-Hsien Chen, Chaur-Jong Hu, Chia-Shin Ho, Shieh-Yueh Yang. (2021).
Using Immunomagnetic Reduction to Assay Reagent Stability of Biomarkers Associated with Alzheimer’s Disease.
Neurological Disorders, Volume 9:2. ISSN: 2329-6895.

Author Affiliations

  1. Department of Neurology, MagQu Co., Ltd., New Taipei City, Taiwan
  2. Department of Neurology, Taipei Medical University, Taipei, Taiwan
  3. Department of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
  4. Department of Neuroscience, Taipei Medical University, Taipei, Taiwan

Assay Methodology

Analysis details the application of immunomagnetic reduction technologies to evaluate stable target threshold tolerances in custom assay components.

Stability Metrics

Quantitative tracking configurations detailing specific reagent performance criteria when identifying key Alzheimer's related plasma variables.

Neurological Disorders Journal Archive Overview

Previous
Previous

Effect of Times to Blood Processing on the Stability of Blood Proteins Associated with Dementia

Next
Next

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles